Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

DMC Biotechnologies

Request full access

DMC Biotechnologies is the low cost sustainable transformation of multiple product markets

Morrisville, United StatesFounded 2014Biotech & Life Sciences

About DMC Biotechnologies

DMC Biotechnologies operates in the biomanufacturing sector, focusing on the sustainable and cost-effective production of bio-based chemicals. The company leverages its innovative technology and metabolic engineering expertise to rapidly commercialize a broad range of bio-based chemicals through precision fermentation. This process allows for the local production of materials using agricultural feedstocks, enabling customers to diversify their supply chains and increase resilience against global disruptions. DMC's business model revolves around collaborating with various industries to provide a reliable and economically sound supply of essential chemicals. The company generates revenue by offering its biomanufacturing services and products to clients in diverse markets, including agriculture, pharmaceuticals, and consumer goods. With a promising pipeline of products under development, DMC aims to revolutionize the chemical production industry by making it more sustainable and efficient.

Source: Dealroom company data

At a glance

Status
Operational
Employees
41
Open positions
2
Dealroom signal
59.8/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Commerce, Chemical, Synthetic Biology, Spinout, Biotech and Pharma, DT and LS, science-based

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Dec 2021 $34M $136M Capricorn Partners · Michelin · SCG · Breakthrough Energy Ventures ↗
SERIES A✓Equity / VC Dec 2019 $1M $4M Capricorn Partners · Boulder Ventures · Breakthrough Energy Ventures · Sofinnova Partners —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

DMC Biotechnologies website traffic

Latest recorded traffic for DMC Biotechnologies is 3.7K monthly website visits, up 37% over the last three months. DMC Biotechnologies's team declined 19.6% over the past year.

Latest monthly visits3.7K 3-month web change+37% 1-year team growth-19.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

DMC Biotechnologies in the Morrisville ecosystem

Live from Dealroom

The DMC Biotechnologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • US National Science Foundation
  • Capricorn Partners

Series A6 investors entered at this stage

  • Boulder Ventures
  • Breakthrough Energy Ventures
  • Sofinnova Partners
  • Cibus Capital
  • Michelin
  • SCG

Other known investors4 additional known investors

Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See DMC Biotechnologies’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.